RavenQuest BioMed Inc.
RVVQF · OTC
10/31/2018 | 10/31/2017 | 10/31/2016 | 10/31/2015 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1,018.8% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.7% | 13% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,168.7% | -2,807.3% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,423.9% | -2,938.1% | – | – |
| EPS Diluted | -0.33 | -0.1 | -0.003 | -0.003 |
| % Growth | -230% | -3,471.4% | -7.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |